Success and failures in MRSA infection control during the COVID-19 pandemic
Abstract Private sector facilities in the United States have experienced a resurgence of Methicillin-resistant Staphylococcus aureus (MRSA) hospital-onset infections during the COVID-19 pandemic, which eliminated all gains that were achieved over the last decade. The third quarter of 2021, the Stand...
Main Authors: | Kevin T. Kavanagh, Lindsay E. Cormier |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-09-01
|
Series: | Antimicrobial Resistance and Infection Control |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13756-022-01158-z |
Similar Items
-
Healthcare Delivery to Traveling Patients in the Veterans Health Administration
by: Al-Haque, Shahed, et al.
Published: (2014) -
Facilitating Patient Flow in a Health Care Delivery Chain
by: Peck, Jordan
Published: (2014) -
Designing a Health Treatment Network: Optimizing Performance in the Modern Health Care Delivery System
by: Peck, Jordan S.
Published: (2014) -
Control of MSSA and MRSA in the United States: protocols, policies, risk adjustment and excuses
by: Kevin T. Kavanagh
Published: (2019-06-01) -
Implementation of MRSA Nasal Swabs as an Antimicrobial Stewardship Intervention to Decrease Anti-MRSA Therapy in COVID-19 Infection
by: Alaina DeKerlegand, et al.
Published: (2023-01-01)